Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, China-Reference-Cited by-同舟云学术

Are We Doing Enough to Stem the Tide of Acquired MDR-TB in Countries with High TB Burden? Results of a Mixed Method Study in Chongqing, China

Published:2014-02-05 Issue:2 Volume:9 Page:e88330
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Li Ying,Ehiri John,Oren Eyal,Hu Daiyu,Luo Xingneng,Liu Ying,Li Daikun,Wang Qingya

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference46 articles.

1. WHO: Global tuberculosis report 2012. Available: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf. Accessed 2013 July 28.

2. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment;LP Ormerod;Br Med Bull,2005

3. Global surveillance for anti-tuberculosis drug resistance 1994–1997. World Health Organization–International Union Against Tuberculosis and Lung Disease Working Group on Anti Tuberculosis Drug Resistance Surveillance;A Pablos-Méndez;N Engl J Med,1998

4. Drug-resistant tuberculosis: time for visionary political leadership;I Abubakar;Lancet Infect Dis,2013

5. A systematic review of the cost and cost effectiveness of treatment for multidrug-resistant tuberculosis;C Fitzpatrick;Pharmacoeconomics,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenge of ending TB in China: tuberculosis control in primary healthcare sectors under integrated TB control model–a systematic review and meta-analysis;BMC Public Health;2024-01-11

2. Molecular epidemiology and transmission dynamics of multi-drug resistant tuberculosis strains using whole genome sequencing in the Amhara region, Ethiopia;BMC Genomics;2023-07-17

3. Factors affecting time to treatment initiation after diagnosis for multidrug‐resistant/rifampicin‐resistant tuberculosis patients: A mixed‐methods study in Jakarta, Indonesia;Tropical Medicine & International Health;2022-12-13

4. Frequency and Management of Adverse Drug Reactions Among Drug-Resistant Tuberculosis Patients: Analysis From a Prospective Study;Frontiers in Pharmacology;2022-06-02

5. Development and validation of self-management scale for tuberculosis patients;BMC Infectious Diseases;2022-05-27